Skip to main content
Journal cover image

Survival prognosis and surgical management of ischemic mitral regurgitation.

Publication ,  Journal Article
Milano, CA; Daneshmand, MA; Rankin, JS; Honeycutt, E; Williams, ML; Swaminathan, M; Linblad, L; Shaw, LK; Glower, DD; Smith, PK
Published in: Ann Thorac Surg
September 2008

BACKGROUND: Ischemic mitral regurgitation (IMR) has an adverse prognosis, but survival characteristics and management are controversial. This study reviewed a 20-year series of IMR patients managed with multiple approaches to assess and refine surgical strategies. METHODS: Patients having surgery for primary coronary disease from 1986 to 2006 were divided into group 1 (no IMR; bypass grafting only; n = 16,209), group 2a (IMR; bypass only; n = 3,181), group 2b (IMR; mitral repair; n = 416), and group 2c (IMR; mitral replacement; n = 106). Cox proportional hazards modeling adjusted for baseline differences, and therapeutic adequacy was quantified by area under each survival curve expressed as a percentage of group 1. RESULTS: Group 2 patients were older than group 1 patients and had worse baseline characteristics. Group 2a had less severe MR and group 2b had the most comorbidity. Assuming group 1 provided the best adjusted outcome at a given baseline risk, group 2a achieved 97.7%, 2b achieved 93.7%, and 2c achieved 79.1% of potential survival (hazard ratio 1.1, 1.4, and 1.6, respectively; p < 0.003). Most of the survival difference was perioperative. CONCLUSIONS: Worse baseline risk is a major factor reducing long-term survival in IMR. Current algorithms in which mild to moderate IMR is managed with bypass only (group 2a) generally produced good late results. In patients with moderate and severe IMR, repair achieved 93.7% of full survival potential; valve replacement was less satisfactory, primarily owing to higher operative mortality. Future therapeutic refinement, emphasizing reparative procedures and better perioperative care, could enhance the surgical prognosis of IMR.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

September 2008

Volume

86

Issue

3

Start / End Page

735 / 744

Location

Netherlands

Related Subject Headings

  • Survival Rate
  • Respiratory System
  • Prognosis
  • Mitral Valve Insufficiency
  • Middle Aged
  • Male
  • Humans
  • Heart Valve Prosthesis
  • Female
  • Coronary Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Milano, C. A., Daneshmand, M. A., Rankin, J. S., Honeycutt, E., Williams, M. L., Swaminathan, M., … Smith, P. K. (2008). Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg, 86(3), 735–744. https://doi.org/10.1016/j.athoracsur.2008.05.017
Milano, Carmelo A., Mani A. Daneshmand, J Scott Rankin, Emily Honeycutt, Matthew L. Williams, Madhav Swaminathan, Lauren Linblad, Linda K. Shaw, Donald D. Glower, and Peter K. Smith. “Survival prognosis and surgical management of ischemic mitral regurgitation.Ann Thorac Surg 86, no. 3 (September 2008): 735–44. https://doi.org/10.1016/j.athoracsur.2008.05.017.
Milano CA, Daneshmand MA, Rankin JS, Honeycutt E, Williams ML, Swaminathan M, et al. Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg. 2008 Sep;86(3):735–44.
Milano, Carmelo A., et al. “Survival prognosis and surgical management of ischemic mitral regurgitation.Ann Thorac Surg, vol. 86, no. 3, Sept. 2008, pp. 735–44. Pubmed, doi:10.1016/j.athoracsur.2008.05.017.
Milano CA, Daneshmand MA, Rankin JS, Honeycutt E, Williams ML, Swaminathan M, Linblad L, Shaw LK, Glower DD, Smith PK. Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg. 2008 Sep;86(3):735–744.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

September 2008

Volume

86

Issue

3

Start / End Page

735 / 744

Location

Netherlands

Related Subject Headings

  • Survival Rate
  • Respiratory System
  • Prognosis
  • Mitral Valve Insufficiency
  • Middle Aged
  • Male
  • Humans
  • Heart Valve Prosthesis
  • Female
  • Coronary Disease